£495.00

It has never been this cheap. We have no record of a lower price.

£495 today · cheaper than every other day in the last 3 months

2023-2028 Orphan Diseases Oncology Therapeutics Outlook China

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 38 days · 38 data points (no recent data)

Historical
Generating forecast…
£495.00 £470.25 £480.15 £490.05 £499.95 £509.85 £519.75 22 August 2026 31 August 2026 09 September 2026 18 September 2026 28 September 2026
View at Amazon ↗

Price data last checked 53 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 38 days • 1 price levels

Days at Price
38 days 0 10 19 29 38 £495 Days at Price

Price Analysis

Most common price: £495 (38 days, 100.0%)

Price range: £495 - £495

Price levels: 1 different prices over 38 days

Description

This comprehensive market research study examines the latent demand outlook for orphan diseases therapeutics in oncology across all regions of China, including provinces, autonomous regions, municipalities, special administrative regions and Taiwan. The analysis covers potential industry earnings (P.I.E.) estimates spanning approximately 1,100 cities throughout China, providing detailed market intelligence for healthcare professionals, pharmaceutical companies, and investors seeking to understand emerging opportunities in China's orphan oncology therapeutics sector. The study delivers region-specific demand forecasts and city-level market share data essential for strategic planning and investment decisions in this specialised healthcare segment.

Key Features

Covers orphan diseases therapeutics in oncology across all Chinese regions including provinces, autonomous regions, municipalities, and special administrative regions.

Provides latent demand forecasts and potential industry earnings estimates for approximately 1,100 cities throughout China.

Includes market analysis for Hong Kong, Macau, and Taiwan alongside mainland China regions.

Delivers city-level market share percentages to help identify regional distribution of demand across China's healthcare markets.

Prepared by ICON Group International, Inc. with data spanning the 2023-2028 forecast period for strategic planning.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
16 August 2022
Listed Since
25 August 2022

Similar Products You Might Like

The 2023-2028 Outlook for Orphan Biologic Drugs in India
90% match

The 2023-2028 Outlook for Orphan Biologic Drugs in India

£515.00 27 Sep 2026
2023-2028 Acute Agitation Aggression Treatments Outlook China
89% match

2023-2028 Acute Agitation Aggression Treatments Outlook China

£495.00 28 Sep 2026
The 2023-2028 Outlook for Immune-Oncology Treatments in India
89% match

The 2023-2028 Outlook for Immune-Oncology Treatments in India

£515.00 27 Sep 2026
2023-2028 Hypercalcemia Treatment Outlook for China
88% match

2023-2028 Hypercalcemia Treatment Outlook for China

£495.00 28 Sep 2026
The 2023-2028 Outlook for Oncolytic Virus Immunotherapies in the United States
88% match

The 2023-2028 Outlook for Oncolytic Virus Immunotherapies in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Cutaneous Melanoma Therapeutics in India
87% match

The 2023-2028 Outlook for Cutaneous Melanoma Therapeutics in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Chemotherapy-Induced Nausea and Vomiting Drugs in the United States
87% match

The 2023-2028 Outlook for Chemotherapy-Induced Nausea and Vomiting Drugs in the United States

£520.00 27 Sep 2026
2023-2028 Home Health Care Services Outlook for China
87% match

2023-2028 Home Health Care Services Outlook for China

£495.00 28 Sep 2026
The 2023-2028 Outlook for Malignant Melanoma Treatments in India
87% match

The 2023-2028 Outlook for Malignant Melanoma Treatments in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in India
87% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Chronic Disease Management Therapeutics and Device Technologies in the United States
87% match

The 2023-2028 Outlook for Chronic Disease Management Therapeutics and Device Technologies in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Pet Veterinary Drugs in China
87% match

The 2023-2028 Outlook for Pet Veterinary Drugs in China

£495.00 15 Sep 2026
The 2023-2028 Outlook for Triple-Negative Breast Cancer Treatments in the United States
87% match

The 2023-2028 Outlook for Triple-Negative Breast Cancer Treatments in the United States

£520.00 27 Sep 2026
The 2019-2024 Outlook for Antibody Drugs in China
87% match

The 2019-2024 Outlook for Antibody Drugs in China

£446.25 27 Sep 2026
The 2023-2028 Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs in the United States
87% match

The 2023-2028 Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs in the United States

£520.00 27 Sep 2026
2023-2028 Outlook: Organic Rice Protein Concentrates China
87% match

2023-2028 Outlook: Organic Rice Protein Concentrates China

£495.00 28 Sep 2026
The 2025-2030 World Outlook for Immuno-Oncology
86% match

The 2025-2030 World Outlook for Immuno-Oncology

£790.00 28 Sep 2026
The 2023-2028 Outlook for Colorectal Cancers for US Zip Codes
86% match

The 2023-2028 Outlook for Colorectal Cancers for US Zip Codes

£490.00 27 Sep 2026
China Contraceptive Implantable Drug Delivery Devices 2023-2028 Outlook
86% match

China Contraceptive Implantable Drug Delivery Devices 2023-2028 Outlook

£495.00 28 Sep 2026
The 2016-2021 Outlook for Pharmaceutical Preparations for Human Use Affecting Neoplasms, the Endocrine System, and Metabolic Diseases in Greater China
86% match

The 2016-2021 Outlook for Pharmaceutical Preparations for Human Use Affecting Neoplasms, the Endocrine System, and Metabolic Diseases in Greater China

£595.00 28 Sep 2026
The 2023-2028 Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs in India
86% match

The 2023-2028 Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs in India

£515.00 27 Sep 2026
2023-2028 Viral Clearance Services Outlook China
86% match

2023-2028 Viral Clearance Services Outlook China

£495.00 28 Sep 2026
2023-2028 Mycotoxin Binders Outlook for China - Market Analysis
86% match

2023-2028 Mycotoxin Binders Outlook for China - Market Analysis

£495.00 28 Sep 2026
The 2023-2028 Outlook for Cystic Fibrosis Therapeutics for US Zip Codes
86% match

The 2023-2028 Outlook for Cystic Fibrosis Therapeutics for US Zip Codes

£490.00 27 Sep 2026